The sex ratio in amyotrophic lateral sclerosis: A population based study

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 5, 2010, Pages 439-442

  Manjaly, Zita R ^a,b   Scott, Kirsten M ^a   Abhinav, Kumar ^b   Wijesekera, Lokesh ^b   Ganesalingam, Jeban ^b   Goldstein, Laura H ^b   Janssen, Anna ^b   Dougherty, Andrew ^b   Willey, Emma ^b   Stanton, Biba R ^b   Turner, Martin R ^c,d   Ampong, Mary Ann ^a   Sakel, Mohammed ^e   Orrell, Richard W ^f   Howard, Robin ^f   Shaw, Chris E ^b   Leigh, P Nigel ^b   Al Chalabi, Ammar ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^f NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Epidemiology; Menopause; Oestrogen; Testosterone

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; MALE; MENOPAUSE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX RATIO; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SEX RATIO; YOUNG ADULT;

EID: 77956622688     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482961003610853     Document Type: Article

References (15)

1. Beghi E, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, et al. The epidemiology of ALS and the role of population based registries. Biochim Biophys Acta. 2006; 1762:1150-7.
2. Armon C. An evidence based medicine approach to the evalu ation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22: 217-28.
3. Mitchell JD. Amyotrophic lateral sclerosis: toxins and environment. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Sep;1(4):235-50.
4. Roman GC. Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatry. 1996;61:131-7.
5. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population based study. Neurology. 1999;52:504-9.
6. Piemonte and Valle dAosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56:239-44.
7. OToole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2008;79:30-2.
8. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6-11.
9. Forbes RB, Colville S, Swingler RJ, Scottish ALS/MND Register. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or over. Age Ageing. 2004;33:131-4.
10. Abhinav K, Stanton B, Johnston C, Hardstaff J, Orrell RW, Howard R, et al. Amyotrophic lateral sclerosis in south-east England: a population based study (South-East England register for Amyotrophic Lateral Sclerosis (SEALS) registry). Neuroepidemiol. 2007;29:44-8.
11. Eisen A. Clinical Neurophysiology of the Motor Neurone Diseases. USA: Elsevier; 2004. pp. 1-3.
12. Chancellor AM, Hendry A, Caird FI, Warlow CP, Weir AI. Motor neuron disease: a disease of old age. Scott Med J. 1993;38:178-82.
13. Drife J, Magowan B. Clinical Obstetrics and Gynaecology. Edinburgh: Saunders; 2004. p. 233.
14. Office of National Statistics. Commissioned table C0381, received 18/07/07. London, ONS. 2007. http://www.statistics. gov.uk/census2001/downloads/ com-tab-finder.xls (accessed 24/04/2008).
15. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G, SLALOM Group. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141-5.